Publication:
Systemic Inflammatory Markers for Prediction of Bevacizumab Benefit in Glioblastoma Multiforme.

Simple item page
dc.contributor.authorBesiroglu, Mehmet
dc.contributor.authorShbair, Abdallah Tm
dc.contributor.authorYasin, Ayse Irem
dc.contributor.authorTopcu, Atakan
dc.contributor.authorTurk, HACI MEHMET
dc.contributor.authorDemir, Tarik
dc.contributor.institutionauthorTÜRK, HACI MEHMET
dc.date.accessioned2021-02-09T20:59:07Z
dc.date.available2021-02-09T20:59:07Z
dc.date.issued2021-01-01T00:00:00Z
dc.identifier.citationBesiroglu M., Shbair A. T. , Yasin A. I. , Topcu A., Turk H. M. , Demir T., -Systemic Inflammatory Markers for Prediction of Bevacizumab Benefit in Glioblastoma Multiforme.-, Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, cilt.31, ss.39-44, 2021
dc.identifier.doi10.29271/jcpsp.2021.01.39
dc.identifier.pubmed33546531
dc.identifier.scopus85100311893
dc.identifier.urihttp://hdl.handle.net/20.500.12645/28373
dc.titleSystemic Inflammatory Markers for Prediction of Bevacizumab Benefit in Glioblastoma Multiforme.
dc.typeArticle
dspace.entity.typePublication
local.avesis.id386b92f3-0ffb-4a36-a1a4-a221f53b0d34
local.indexed.atPubMed
local.indexed.atScopus
local.publication.isinternational1
relation.isAuthorOfPublication1b3a1540-7e57-405d-8a9d-f926d17dcc29
relation.isAuthorOfPublication.latestForDiscovery1b3a1540-7e57-405d-8a9d-f926d17dcc29

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Bulletin_pdf (1).pdf
Size:
719.52 KB
Format:
Adobe Portable Document Format
Description:
Download

Collections

Yayınlar - Eserler